Inhibition of antitumor immunity by B cells [5]

Cancer Research

Volumn 67, Issue 10, 2007, Pages 5058-5059

  Rosenblatt, Joseph ^a   Yu, Dana Zhang ^a   Tadmor, Tamar ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

B LYMPHOCYTE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; LETTER; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; B-LYMPHOCYTES; INTERFERON TYPE II; INTERLEUKIN-10; MICE; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 34250313100     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3903     Document Type: Letter

References (4)

1. Inoue S, Leitner WW, Golding B, Scott D. Inhibitory effects of B cells on antitumor immunity. Cancer Res 2006;66:7741-7.
2. Shah S, Divekar AA, Hilchey SP, et al. Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and Th1 cytokine responses by B cells. Int J Cancer 2005;117:574-86.
3. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006;176:705-10.
4. Burke F, Stagg AJ, Bedford PA, English N, Knight SC. IL-10-Producing B220+CD11c-APC in mouse spleen. J Immunol 2004;173:2362-72.